Navigation Links
ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
Date:12/6/2011

EXTON, Pa., Dec. 6, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) and Halozyme Therapeutics (Nasdaq: HALO) today announced positive top line data from ViroPharma's open-label, multiple dose Phase 2 clinical trial designed to evaluate the safety, pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze® (C1 esterase inhibitor [human)] in combination with Halozyme's Enhanze™ technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme (rHuPH20), in subjects with hereditary angioedema (HAE), a rare, debilitating and potentially fatal genetic disease.

In this study, the addition of rHuPH20 led to higher maximum levels and greater systemic exposure of functional and antigenic C1 inhibitor (C1 INH) for both Cinryze doses evaluated (1000 and 2000 units) as compared to subcutaneous administration of Cinryze alone.  In addition, administration of Cinryze with rHuPH20 resulted in mean functional C1 INH levels that are clinically relevant and potentially associated with protection against HAE attacks. The most commonly reported adverse events are mild local injection site reactions such as erythema and pain. 

Complete data are expected to be presented at a future international scientific meeting.

"We are very encouraged by these initial data from this Phase 2 study of subcutaneous delivery of Cinryze in combination with rHuPH20, which are informative for the trial design of the upcoming Phase 2 dose ranging combination study," commented Colin Broom, MD, ViroPharma's chief scientific officer.  "These preliminary data suggest that rHuPH20 enhances the delivery and absorption of Cinryze, and increases systemic exposure to C1 inhibitor relative to subcutaneous Cinryze administered alone. We
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ViroPharma to Participate in Two November Healthcare Investor Conferences
2. ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline
3. ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
4. ViroPharma to Release 2011 Third Quarter Financial Results on October 27, 2011
5. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
6. ViroPharma Announces Additional Securities Repurchase Program
7. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
8. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
9. ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
10. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
11. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching ... cronuts: 1-800 CONTACTS announces their new Apple Watch app which ... Two taps. New contacts. From your watch. ... also features LensGauge which helps keep track of how long ... reorder. "Since our inception, we,ve been dedicated to ...
(Date:4/24/2015)... -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, ... from Mylan NV ("Mylan") (NASDAQ: MYL ) to ... $60.00 per share in cash and 2.2 Mylan ordinary ... The Board previously concluded that Mylan,s unsolicited ... and its future growth prospects and was not in ...
(Date:4/24/2015)... WHIPPANY, N.J. , April 24, 2015  Bayer Corporation ... Thursday, April 23 at the Bayer HealthCare US headquarters.  This ... relocating to the Whippany campus, and ... and Dad do every day at work. Fortunately, ... the office.  As a company whose mission is "Science For ...
Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4
... Pharmaceuticals, which in October secured a $30 million funding ... signing of a long term lease on a manufacturing ... addition of Dr. Hemant Misra to the Prolong Executive ... The manufacturing facility has been used ...
... NEWPORT BEACH, Calif., Jan. 25, 2011 Every business needs ... advantage; others use a differentiation advantage. Hospitals are not immune ... doctors. Dr. Barry Friedberg says if hospitals ... to institute the use of a brain monitor in all ...
Cached Medicine Technology:Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team 2If Hospitals Want a Competitive Advantage - Use Brain Monitors in Surgeries Requiring Sedation says Renowned Anesthesiologist 2
(Date:4/24/2015)... Eastern Star Masonic Home is hosting an Open House to ... from 1:30-3:00 pm. , Residents from Boone and the surrounding ... opening of the new community room. Light refreshments will be ... to anyone who wishes to visit the rest of the ... be available for use by residents of the facility as ...
(Date:4/24/2015)... Buffalo, New York (PRWEB) April 24, 2015 ... has partnered with Allergy and Asthma Network (The Network), ... PURE Solutions will provide news, tips and information ... on The Network’s newly redesigned website. , The goal ... raising awareness about the travel needs of people with ...
(Date:4/24/2015)... 2015 E-Factor Diet claims to be a ... stress and allows people to enjoy food as rapid weight ... HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... blueprint that Jared used to lose weight, and all the ... included inside. This is a diet for people who are ...
(Date:4/24/2015)... Del Mar, CA (PRWEB) April 24, 2015 ... newest addition to the staff, Jamie Johansen. She will ... practice, including human resources, patient relations, and reporting. Jamie ... spa and cosmetic surgery sector as the new Practice ... Operations at LaserAway and Practice Manager at American Laser ...
(Date:4/23/2015)... 23, 2015 Fitnet , the only ... now, an accurate calorie counter during video exercise, is featured ... Health and Fitness categories in the Apple Watch App Store ... of the Digital age," now allows clients to use it ... only third party app providing accurate calorie burn counter, cardio ...
Breaking Medicine News(10 mins):Health News:PURE Solutions Partners with Allergy and Asthma Network to Provide Allergy Travel Tips 2Health News:E-Factor Diet: Review Examining John Rowley’s Brand New Weight Loss Program Released 2Health News:Fitnet Handpicked as Top Healthy Living App in Apple Watch Store 2Health News:Fitnet Handpicked as Top Healthy Living App in Apple Watch Store 3
... discovered a protein signaling pathway that becomes hyperactivated in human ... be effective in the treatment of human sarcomas. The ... Cancer Cell . A team of researchers led ... and Chairman of the Department of Oncological Sciences at Mount ...
... St. Louis, MO 23 May, 2011 ... and medical information products and services, announced today ... (METI), a leading manufacturer of medical simulation and ... to release a turn-key health care education product ...
... researchers, including a number from the University of North Carolina ... the genome that contribute to the debilitating lung disease that ... provide insight into the causes of the wide variation in ... the way to new diagnostic markers and therapeutic approaches for ...
... the name of an infection that causes a series of reactions ... The problem for both patients and doctors is that the early ... a severe flu or winter vomiting disease. A researcher at Lund ... which shows both whether a patient has sepsis and how serious ...
... SUNDAY, May 22 (HealthDay News) -- New Swedish research ... major cardiovascular complications among patients who have a ... builds on earlier work that was published by the ... That study suggested that Inspra (eplerenone), an aldosterone antagonist, ...
... the Florida campus of The Scripps Research Institute have for ... natural product isolated from the bark of a plant widely ... foundation to develop an effective alternative to commonly prescribed narcotic ... in an advanced online edition of the journal Nature ...
Cached Medicine News:Health News:Mount Sinai researchers discover possible new target for sarcoma treatment and prevention 2Health News:Elsevier and METI collaborate to offer simulation technology for health science curriculums 2Health News:Consortium identifies genome regions that could influence severity of cystic fibrosis 2Health News:Consortium identifies genome regions that could influence severity of cystic fibrosis 3Health News:Quicker detection and treatment of severe sepsis 2Health News:Blood Pressure Drug Helps Those With Mild Heart Failure 2Health News:Led by advances in chemical synthesis, scientists find natural product shows pain-killing properties 2Health News:Led by advances in chemical synthesis, scientists find natural product shows pain-killing properties 3
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
World's first commercially available vacuum assisted biopsy device for MRI....
... stereotactic, ultrasound and MRI-guided vacuum assisted breast ... Use the patented, FDA-cleared ATEC system for ... advanced method of breast biopsy. Its compassionate ... who trust YOU.,9 Gauge Handpieces: Useful for ...
... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,9 Gauge Handpieces: Useful for biopsy ...
Medicine Products: